Radafaxine (CHEM131343)
| Record Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||
| Creation Date | 2026-04-14 18:23:22 UTC | ||||||||
| Update Date | 2026-08-19 01:18:31 UTC | ||||||||
| Accession Number | CHEM131343 | ||||||||
| Identification | |||||||||
| Common Name | Radafaxine | ||||||||
| Class | Small Molecule | ||||||||
| Description | Radafaxine is an organic compound with the formula C13H18ClNO2 and an average molecular weight of 255.74 g/mol. Radafaxine belongs to the morpholines, a subclass of oxazinanes within the organic compounds. It is classified as an organoheterocyclic compound. Regarding its biological activity, two protein targets are recorded for this substance. Radafaxine acts as an inhibitor of the sodium-dependent dopamine transporter (SLC6A3) and the sodium-dependent noradrenaline transporter (SLC6A2). | ||||||||
| Contaminant Sources | Not Available | ||||||||
| Contaminant Type | Not Available | ||||||||
| Chemical Structure |  | ||||||||
| Synonyms | Not Available | ||||||||
| Chemical Formula | C13H18ClNO2 | ||||||||
| Average Molecular Mass | 255.740 g/mol | ||||||||
| Monoisotopic Mass | 255.103 g/mol | ||||||||
| CAS Registry Number | 192374-14-4 | ||||||||
| IUPAC Name | (2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethylmorpholin-2-ol | ||||||||
| Traditional Name | Not Available | ||||||||
| SMILES | C[C@@H]1NC(C)(C)CO[C@@]1(O)C1=CC=CC(Cl)=C1 | ||||||||
| InChI Identifier | InChI=1S/C13H18ClNO2/c1-9-13(16,17-8-12(2,3)15-9)10-5-4-6-11(14)7-10/h4-7,9,15-16H,8H2,1-3H3/t9-,13+/m0/s1 | ||||||||
| InChI Key | RCOBKSKAZMVBHT-TVQRCGJNSA-N | ||||||||
| Chemical Taxonomy | |||||||||
| Classification | Not classified | ||||||||
| Biological Properties | |||||||||
| Status | Detected and Not Quantified | ||||||||
| Origin | Not Available | ||||||||
| Cellular Locations | Not Available | ||||||||
| Biofluid Locations | Not Available | ||||||||
| Tissue Locations | Not Available | ||||||||
| Pathways | Not Available | ||||||||
| Applications | Not Available | ||||||||
| Biological Roles | Not Available | ||||||||
| Chemical Roles | Not Available | ||||||||
| Physical Properties | |||||||||
| State | Not Available | ||||||||
| Appearance | Not Available | ||||||||
| Experimental Properties |
| ||||||||
| Predicted Properties | Not Available | ||||||||
| Spectra | |||||||||
| Spectra |
| ||||||||
| Toxicity Profile | |||||||||
| Route of Exposure | Not Available | ||||||||
| Mechanism of Toxicity | Not Available | ||||||||
| Metabolism | Not Available | ||||||||
| Toxicity Values | Not Available | ||||||||
| Lethal Dose | Not Available | ||||||||
| Carcinogenicity (IARC Classification) | Not Available | ||||||||
| Uses/Sources | Not Available | ||||||||
| Minimum Risk Level | Not Available | ||||||||
| Health Effects | Not Available | ||||||||
| Symptoms | Not Available | ||||||||
| Treatment | Not Available | ||||||||
| Concentrations | |||||||||
| Not Available | |||||||||
| External Links | |||||||||
| Identifiers | Not Available | ||||||||
| References | |||||||||
| Synthesis Reference | Not Available | ||||||||
| MSDS | Not Available | ||||||||
| General References | Not Available | ||||||||
